Rad AI
Rad AI develops generative AI software for radiology. Its Omni platform automates report impressions, saving time and reducing burnout.
Secondary Market Price
Secondary Market Price
How Rad AI Measures Up
To help you manage your Rad AI equity, Prospect has run the company through our machine learning model.
Prospect Rating
TBD
We are still gathering data and evaluating Rad AI, so we have not yet issued a rating. Please check back soon for our projection of the company's worth four years from now.
Exit Risk
TBD
We are still gathering data on Rad AI to train our machine learning model. Check back soon for our exit risk rating for Rad AI!
Funding Stage
Series C
Reaching the Series C stage means Rad AI is an established company that's now focused on rapid expansion. For a potential employee, this offers a balance of stability and the opportunity to be part of a company's major growth phase.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Rad AI's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Rad AI Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Rad AI's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Rad AI is a software development company that creates generative artificial intelligence platforms for healthcare, with a specific focus on radiology. The company's products, which include Rad AI Omni, Rad AI Reporting, and Rad AI Continuity, are designed to integrate into existing radiologist workflows to automate tasks like generating report impressions from dictated findings. Founded in 2018 by Doktor Gurson and Jeff Chang, the San Francisco-based company has grown to approximately 189 employees. Rad AI has raised a total of $157 million through several funding rounds and acquired Equium Intelligence in November 2022.
Looking forward, the company is focused on expanding the capabilities and adoption of its platform. A recent partnership with the Radiological Society of North America (RSNA) aims to integrate real-time, peer-reviewed insights directly into radiology workflows. In a case study with LucidHealth, the adoption of Rad AI's tools resulted in a reported 11% increase in productivity per shift and a 6% reduction in exam turnaround times. The company's growth is supported by a Series C funding round of $72.9 million completed in January 2025, with investors including healthcare systems like Corewell Health and Advocate Health.
- Khosla
- Gradient Ventures
- World Innovation Lab
- Transformation Capital
- Artis Ventures
- Kickstart
- Co-Founder, CEO Doktor Gurson
- Co-Founder, CPO Jeff Chang
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Rad AI worth joining?
Deciding whether to join any startup involves assessing its growth potential, leadership, and the value of its equity offer. Platforms like Prospect can help you evaluate the opportunity by providing data-driven projections on the company's future value and what your equity might be worth.
What should I do with my Rad AI stock?
Managing pre-IPO stock requires careful planning around exercising options and preparing for liquidity events to maximize your post-tax returns. Tools like Prospect offer personalized strategies and predictive models to help you make informed decisions about your equity.
Can you sell Rad AI stock?
Selling stock in a private company is typically possible through company-approved tender offers or on secondary markets, though it is less straightforward than selling public stock. Financial tools can help you navigate these opportunities by identifying tax-optimal shares to sell and analyzing secondary market prices.
How can I find the value of my Rad AI stock?
The value of stock in a private company is typically based on its most recent 409A valuation, but its future worth can be projected using various data points. Platforms like Prospect use models similar to those of venture capitalists to forecast equity value based on fundraising, growth metrics, and market data.
What is Rad AI's equity worth?
The precise worth of a private company's equity is not public information and depends on factors like its latest valuation and overall performance. You can estimate its potential value using platforms that analyze company data, investor quality, and growth metrics to provide independent projections.
What is Rad AI's stock ticker symbol?
As a private company, Rad AI does not have a stock ticker symbol because it is not traded on a public stock exchange. Ticker symbols are only assigned to companies once they complete an Initial Public Offering (IPO).
Can I buy or sell Rad AI stock?
Buying stock in a private company is generally restricted to accredited investors and employees, while selling is often limited to company-sanctioned liquidity events like tender offers. These transactions occur on secondary markets and are not as simple as trading public stocks.
What is the criteria to buy or invest in Rad AI stock?
To invest in a private company like Rad AI, you generally must be an accredited investor, a status defined by financial regulators based on income or net worth. Employees may also receive equity as part of their compensation without meeting this criteria.
